U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Withdrawn Blood Memoranda
  1. Search for FDA Guidance Documents

Withdrawn Blood Memoranda

 

Title Date Issued
(year-month-day)  		 Date Withdrawn
(year-month-day) 

Reviewer Guidance for a Premarket Notification Submission For Blood Establishment Computer Software

 1997-01-13 2020-07-16

Draft Document Concerning the Regulation of Peripheral Blood Hematopoietic Stem Cell Products Intended for Transplantation or Further Manufacturing Into Injectable Products

 1996-02-01 2020-07-16

Draft Document Concerning the Regulation of Placental/Umbilical Cord Blood Stem Cell Products Intended for Transplantation or Further Manufacturing Into Injectable Products

 1995-12-01 2020-07-16

Recommendations for Labeling and Use of Units of Whole Blood, Blood Components, Source Plasma, Recovered Plasma or Source Leukocytes Obtained from Donors with Elevated Levels of Alanine Aminotransferase (ALT)

 1995-08-08

2020-07-16

Memorandum to All Registered Blood Establishments - Recommendations for the Deferral of Current and Recent Inmates of Correctional Institutions as Donors of Whole Blood, Blood Components, Source Leukocytes, and Source Plasma

1995-06-08

2020-07-16

Memorandum to Registered Blood and Source Plasma Establishments, Revision of FDA Memorandum of August 27,1982: Requirements for Infrequent Plasmapheresis Donors

1995-03-10

2020-07-16

Memorandum to Registered Blood Establishments, Timeframe for Licensing Irradiated Blood Products

1995-02-03

2020-07-16

Memorandum to Registered Blood Establishments, Recommendations to Users of Medical Devices That Test for Infectious Disease Markers by Enzyme Immunoassay (EIA) Test Systems

1994-12-20

2020-07-16

Draft Recommend-Quarantine and Disposition of Potentially HBV, HCV or HTLV-1 Contaminated Units from Prior Collections from Repeat Donors with Repeatedly Reactive Screening Tests

1994-11-22

2020-07-16

Memorandum to Registered Blood Establishments - Use of an FDA Cleared or Approved Sterile Connecting Device (STCD) in Blood Bank Practices

1994-08-05

2020-07-16

Recipient Serum Samples

1994-04-06

2020-07-16

Software Used in Blood Establishments

1994-03-31

2020-07-16

Clarification of the Use of Unlicensed Anti-HCV Supplemental Test Results in Regard to Donor Notification

1993-08-19

2020-07-16

Deferral of Blood and Plasma Donors Based on Medications

1993-07-28

2020-07-16

Revision of October 7, 1988 Memorandum Concerning Red Blood Cell Immunization Programs

1992-12-16

2020-07-16

Nomenclature for Monoclonal Blood Grouping Reagents

1992-09-28

2020-07-16

Change in Equipment for Processing Blood Donor Samples

1992-07-21

2020-07-16

Inspections of Military Blood Establishments, Revised Instructions for Command Notification

1992-06-18

2020-07-16

Use of Fluorognost HIV-1 Immunofluorescent Assay (IFA)

1992-04-23

2020-07-16

Clarification of FDA Recommendations for Donor Deferral and Product Distribution Based on the Results of Syphilis Testing

1991-12-12

2020-07-16

Disposition of Blood Products Intended for Autologous use that Test Repeatedly Reactive for Anti-HCV

1991-09-11

2020-07-16

Revision to 26 October 1989 Guideline for Collection of Blood or Blood Products from Donors with Positive Tests for Infectious Disease Markers ("High Risk" Donors)

1991-04-17

2020-07-16

Deficiencies Relating to the Manufacture of Blood and Blood Components

1991-03-20

2020-07-16

FDA Request for Information on Blood Storage Patterns and Red Cell Contamination by Yersinia Enterocolitica

1991-03-15

2020-07-16

Use of Genetic Systems HIV-2 EIA

1990-06-21

2020-07-16

Autologous Blood Collection and Processing Procedures

1990-02-12

2020-07-16

Eight-Hour Hold; Blood and Plasma Inspectors

1989-11-13

2020-07-16

Abbott Laboratories' HIVAG-1 test for HIV-1 antigen(s) not recommended for use as a donor screen

1989-10-04

2020-07-16

Requirements for Computerization of Blood Establishments

1989-09-08

2020-07-16

Use of the Recombigen HIV-1 Latex Agglutination (LA) Test

1989-08-01

2020-07-16

Guidance for Autologous Blood and Blood Components

1989-03-15

2020-07-16

Use of the Recombigen HIV-1 LA Test

1989-02-01

2020-07-16

Antibody to Human T-Cell Lymphotropic Virus, Type I (HTLV-1) Release Panel 1

1988-10-18

2020-07-16

Revised Guidelines for the Collection of Platelets, Pheresis

1988-10-07

2020-07-16

Criteria for Exemption of Lot Release

1988-08-26

2020-07-16

Physician Substitutes (Update)

1988-08-15

2020-07-16

Discontinuance of Pre-Licensing Inspection for Immunization Using Licensed Tetanus Toxoid and Hepatitis B and Rabies Vaccines

1988-07-07

2020-07-16

Recommendations for Implementation of Computerization in Blood Establishments

1988-04-06

2020-07-16

Control of Unsuitable Blood and Blood Components

1988-04-06

2020-07-16

Handling of Human Blood Source Materials

1987-12-23

2020-07-16

Extension of Dating Period For Storage of Red Blood Cells, Frozen

1987-12-04

2020-07-16

Deferral of Donors Who Have Received Human Pituitary-Derived Growth Hormone

1987-11-25

2020-07-16

Reduction of the Maximum Platelet Storage Period tp 5 Days in an Approved Container

1986-06-02

2020-07-16

In Vitro Diagnostic Reagent Manufacturers - Guidance for Labeling for HTLV-III/LAV Antibody Testing

1985-12-06

2020-07-16

Physician Substitutes

1984-12-14

2020-07-16

Equivalent Methods for Compatibility Testing

1984-12-14

2020-07-16

Deferral of Blood Donors Who Have Received the Drug Accutane (isotretinoin / Roche; 13-cis-retinoic acid)

1984-02-28

2020-07-16

Collection of Human Leukocytes for Further Manufacturing (Source Leukocytes)

1981-01-28

2020-07-16

 

 

Back to Top